Neutrophil gelatinase-associated lipocalin (NGAL) in human neoplasias: A new protein enters the scene
The DOI matches its Crossref record; 30 of the 30 references it cites were found in a registry or an index.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The lipocalin protein family: structure and function
FLOWER, D. R. (1996) · Biochemical Journal · doi:10.1042/bj3180001 · Cited by 1,679
NF-κB links innate immunity to the hypoxic response through transcriptional regulation of HIF-1α
Rius, J., Guma, M., Schachtrup, C., Akassoglou, K., Zinkernagel, A. S., Nizet, V., Johnson, R. S., Haddad, G. G., & Karin, M. (2008) · Nature · doi:10.1038/nature06905 · Cited by 1,614
The role of hypoxia-inducible factors in tumorigenesis
Rankin, E. B., & Giaccia, A. J. (2008) · Cell Death & Differentiation · doi:10.1038/cdd.2008.21 · Cited by 806 · cited 1×
“The latter effects, in particular, explain the nature of HIF-1a as an important factor for survival, and proliferation of tumor cells [25].”
BackgroundYan, L., Borregaard, N., Kjeldsen, L., & Moses, M. A. (2001) · Journal of Biological Chemistry · doi:10.1074/jbc.m106089200 · Cited by 676
A Cell-Surface Receptor for Lipocalin 24p3 Selectively Mediates Apoptosis and Iron Uptake
Devireddy, L. R., Gazin, C., Zhu, X., & Green, M. R. (2005) · Cell · doi:10.1016/j.cell.2005.10.027 · Cited by 672 · cited 1×
“[24], the main significance of the increased synthesis of NGAL would be finalized at exploiting the peculiar capacity of this protein to bind iron particles from the extracellular space within the malignant cell: this would satisfy the increased demand for this mineral, fundamental to maintaining tumor multiplication.”
BackgroundAn Iron Delivery Pathway Mediated by a Lipocalin
Yang, J., Goetz, D., Li, J.-Y., Wang, W., Mori, K., Setlik, D., Du, T., Erdjument-Bromage, H., Tempst, P., Strong, R., et al. (2002) · Molecular Cell · doi:10.1016/s1097-2765(02)00710-4 · Cited by 651
Neutrophil Gelatinase–Associated Lipocalin (NGAL) as a Marker of Kidney Damage
Bolignano, D., Donato, V., Coppolino, G., Campo, S., Buemi, A., Lacquaniti, A., & Buemi, M. (2008) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2008.01.020 · Cited by 581
Self-citationNielsen, B. S., Borregaard, N., Bundgaard, J. R., Timshel, S., Sehested, M., & Kjeldsen, L. (1996) · Gut · doi:10.1136/gut.38.3.414 · Cited by 421 · cited 2×
“These discoveries partly explain the observations made in a previous study that demonstrates high levels of NGAL expression in tissue but not in lymphnode metastases from adenocarcinomas of the colon [31], and confirm the potential of NGAL as a possible anti-metastatic agent.”
BackgroundResultLipocalins as biochemical markers of disease
Xu, S., & Venge, P. (2000) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(00)00163-1 · Cited by 285 · cited 1×
“urinary tracts, are associated with a marked increase in the local and systemic expressionofNGAL [4] and, in somecases (e.”
BackgroundFernández, C. A., Yan, L., Louis, G., Yang, J., Kutok, J. L., & Moses, M. A. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2391 · Cited by 283 · cited 3×
“In agreement with these observations, it has been reported that in murine models in vivo the experimental induction of NGAL in a breast tumor cell line with MMP9 hyper-expression leads to an increase in the levels of circulating MMP9 and the appearance of a particularly aggressive tumoral phenotype, with an increased…”
BackgroundResultBauer, M., Eickhoff, J. C., Gould, M. N., Mundhenke, C., Maass, N., & Friedl, A. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-007-9619-3 · Cited by 215 · cited 3×
“[13] Breast carcinoma + 207 samples of breast carcinoma.”
BackgroundResultIannetti, A., Pacifico, F., Acquaviva, R., Lavorgna, A., Crescenzi, E., Vascotto, C., Tell, G., Salzano, A. M., Scaloni, A., Vuttariello, E., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0710846105 · Cited by 210
Ligand Preference Inferred from the Structure of Neutrophil Gelatinase Associated Lipocalin
Goetz, D. H., Willie, S. T., Armen, R. S., Bratt, T., Borregaard, N., & Strong, R. K. (2000) · Biochemistry · doi:10.1021/bi992215v · Cited by 184 · cited 1×
“The principal characteristic of NGAL, on the other hand, is to capture iron particles, the siderophores, and transport them to the inner cell after interacting with specific membrane receptors (24p3R, megalin), thus causing an increase in the cytoplasmic levels of the preciousmineral [2] (Fig.”
BackgroundUrinary Biomarkers Predict Brain Tumor Presence and Response to Therapy
Smith, E. R., Zurakowski, D., Saad, A., Scott, R. M., & Moses, M. A. (2008) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-07-1253 · Cited by 182 · cited 2×
“[17], in particular, show that the NGAL/MMP9 complex is one of the few urinary biomarkers that can predict the presence of an underlying cerebral tumor; moreover, it was found that tumor excision was immediately followed by the normalization of NGAL/MMP9 levels, thus suggesting that the measurement of this parameter m…”
BackgroundLim, R., Ahmed, N., Borregaard, N., Riley, C., Wafai, R., Thompson, E. W., Quinn, M. A., & Rice, G. E. (2007) · International Journal of Cancer · doi:10.1002/ijc.22352 · Cited by 165
Tong, Z., Kunnumakkara, A. B., Wang, H., Matsuo, Y., Diagaradjane, P., Harikumar, K. B., Ramachandran, V., Sung, B., Chakraborty, A., Bresalier, R. S., et al. (2008) · Cancer Research · doi:10.1158/0008-5472.can-08-0540 · Cited by 165
Expression of Neutrophil Gelatinase-associated Lipocalin Regulates Epithelial Morphogenesis in Vitro
Gwira, J. A., Wei, F., Ishibe, S., Ueland, J. M., Barasch, J., & Cantley, L. G. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413192200 · Cited by 165 · cited 1×
“Moreover, as observed for other lipocalins, recent findings suggest that NGAL actively participates in the processes of growth,developmentanddifferentiationofdifferenthuman tissues as early as in the embryonic phases, thus signifying that the protein also plays an important role in the regulation of physiological cell…”
BackgroundHeterogeneous expression of the lipocalin NGAL in primary breast cancers
Stoesz, S. P., Friedl, A., Haag, J. D., Lindstrom, M. J., Clark, G. M., & Gould, M. N. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19981218)79:6<565::aid-ijc3>3.0.co;2-f · Cited by 155 · cited 3×
“[12], demonstrated a close correlation between the intensity of tissue NGAL expression and some indicators of a poor prognosis, such as a low grade of differentiation, the presence of lymphnode metastases and a high proliferation index.”
BackgroundResultInfluentialKubben, F. J. G. M., Sier, C. F. M., Hawinkels, L. J. A. C., Tschesche, H., van Duijn, W., Zuidwijk, K., van der Reijden, J. J., Hanemaaijer, R., Griffioen, G. G., Lamers, C. B. H. W., et al. (2007) · European Journal of Cancer · doi:10.1016/j.ejca.2007.05.013 · Cited by 149
Bratt, T. (2000) · Biochimica et Biophysica Acta (BBA) - Protein Structure and Molecular Enzymology · doi:10.1016/s0167-4838(00)00154-0 · Cited by 145 · cited 2×
“In the case of NGAL, it has been demonstrated in various experimental models in vitro that some factors traditionally promoting the development of neoplasias, such as the hepatocyte growth factor, the neu-transforming factor, the phorbol ester PMA, retinoic acid, poliomavirus infection and even glycocorticoids can ind…”
BackgroundMethodLipocalin 2 Diminishes Invasiveness and Metastasis of Ras-transformed Cells
Hanai, J.-I., Mammoto, T., Seth, P., Mori, K., Karumanchi, S. A., Barasch, J., & Sukhatme, V. P. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413047200 · Cited by 123
Lee, H., Lee, E., Lee, K., Hong, S., Yoon, Y., & Kim, J. (2006) · International Journal of Cancer · doi:10.1002/ijc.21657 · Cited by 118 · cited 3×
“An evident anti-metastatic action that again evidences the uncertainty regarding the exact relations between NGAL and tumors was recently described for colon cancer [30].”
BackgroundZhang, H., Xu, L., Xiao, D., Xie, J., Zeng, H., Wang, Z., Zhang, X., Niu, Y., Shen, Z., Shen, J., et al. (2007) · Journal of Clinical Pathology · doi:10.1136/jcp.2006.039297 · Cited by 113
Cellular and molecular targets of estrogen in normal human breast tissue.
Seth, P., PORTER, D. A., Lahti‐Domenici, J., Geng, Y., Richardson, A. L., & Polyák, K. (2002) · PubMed · Cited by 96
Garay-Rojas, E., Harper, M., Hraba-Renevey, S., & Kress, M. (1996) · Gene · doi:10.1016/0378-1119(95)00896-9 · Cited by 89 · cited 1×
“In the case of NGAL, it has been demonstrated in various experimental models in vitro that some factors traditionally promoting the development of neoplasias, such as the hepatocyte growth factor, the neu-transforming factor, the phorbol ester PMA, retinoic acid, poliomavirus infection and even glycocorticoids can ind…”
MethodStoesz, S. P., & Mn, G. (1995) · PubMed · Cited by 59
Fang, W.-K., Xu, L.-Y., Lu, X.-F., Liao, L.-D., Cai, W.-C., Shen, Z.-Y., & Li, E.-M. (2007) · Biochemical Journal · doi:10.1042/bj20060836 · Cited by 53
Davis, T. R., Tabatabai, L. B., Bruns, K. A., Hamilton, R. T., & Nilsen‐Hamilton, M. (1991) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(91)90077-b · Cited by 49 · cited 1×
“In the case of NGAL, it has been demonstrated in various experimental models in vitro that some factors traditionally promoting the development of neoplasias, such as the hepatocyte growth factor, the neu-transforming factor, the phorbol ester PMA, retinoic acid, poliomavirus infection and even glycocorticoids can ind…”
MethodLipocalin 2 Antagonizes the Proangiogenic Action of Ras in Transformed Cells
Venkatesha, S., Hanai, J., Seth, P., Karumanchi, S. A., & Sukhatme, V. P. (2006) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-06-0110 · Cited by 41 · cited 1×
“For example, in a model of malignant RAS-transformed cells, NGAL expression (especially if accompanied by the addition of siderophores to the medium) induced an epithelial phenotype to mesenchymal tumor cells, blocking in vivo their capacity for growth, invasiveness and metastasization, as well as their angiogenesis […”
BackgroundApolipoprotein D predicts adverse outcome in women ≥70 years with operable breast cancer
Søiland, H., Janssen, E. A. M., Kørner, H., Varhaug, J. E., Skaland, I., Gudlaugsson, E. G., Baak, J. P. A., & Søreide, J. A. (2008) · Breast Cancer Research and Treatment · doi:10.1007/s10549-008-9955-y · Cited by 24
Cited by
Vandooren, J., Van den Steen, P. E., & Opdenakker, G. (2013) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.3109/10409238.2013.770819 · Cited by 766
Chakraborty, S., Kaur, S., Guha, S., & Batra, S. K. (2012) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2012.03.008 · Cited by 503
S100A8/A9 activate key genes and pathways in colon tumor progression
Ichikawa, M., Williams, R., Wang, L., Vogl, T., & Srikrishna, G. (2011) · Molecular Cancer Research · doi:10.1158/1541-7786.mcr-10-0394 · Cited by 346
“Neutrophil gelatinase-associated lipocalin-2 encoded by NF-κB inducible Lcn2 gene, has paradoxically both pro and antitumor effects [52].”
BackgroundJung, M., Ören, B., Mora, J., Mertens, C., Dziumbla, S., Popp, R., Weigert, A., Grossmann, N., Fleming, I., & Brüne, B. (2016) · Science Signaling · doi:10.1126/scisignal.aaf3241 · Cited by 87
Pathways driving the endocytosis of mutant and wild-type EGFR in cancer
Hampton, K. K., & Craven, R. J. (2014) · Oncoscience · doi:10.18632/oncoscience.67 · Cited by 35
Metadata
- Authors
- Bolignano, D., Donato, V., Lacquaniti, A., Fazio, M. R., Bono, C., Coppolino, G., & Buemi, M.
- Venue
- Cancer Letters
- Publisher
- Elsevier BV
- Published
- 2010-02
- Volume
- 288
- Issue
- 1
- Pages
- 10-16
- ISSN
- 0304-3835 (ISSN-L)
- OpenAlex
- W1977009545
- Cited by
- 170
- References
- 30
- FWCI
- 4.95
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.